Search

everythinglearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Olanzapine reduces stress-related anxiety in rats when given acutely.

The new delivery method for dutasteride is more effective and has fewer side effects.

A woman developed lupus after taking hydroxyurea for two years.

Tea polyphenol–zinc helps protect the liver and intestines from oxidative stress.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Coenzyme Q10 may protect liver function but doesn't reduce hair loss from anthracycline antibiotics.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Using finasteride and doxazosina together works better for treating benign prostatic hyperplasia than using just one.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Finasteride and SSRIs together increase impotence and low libido risk in men.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

Raltegravir may cause hair loss in some patients.

Tofacitinib treatment for hair loss may worsen acne.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Low-dose flutamide effectively maintains reduced hirsutism with no side effects.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.